Evidence map›Paper›PMID 39148801›Full record

ArticleChemical science2024

Chemo-enzymatic production of base-modified ATP analogues for polyadenylation of RNA.

Rachel M Mitton-Fry, Jannik Eschenbach, Helena Schepers, René Rasche, Mehmet Erguven, Daniel Kümmel, Andrea Rentmeister, Nicolas V Cornelissen

Abstract read
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. An Update: Enzymatic Synthesis for Industrial Applications.Angewandte Chemie (International ed. in English) · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rachel M Mitton-FryInstitute of Biochemistry, University of Münster Corrensstr. 36 D-48149 Münster Germany mittonfryr@denison.edu andrea.rentmeister@cup.lmu.de cornelissen@uni-muenster.de.ORCID https://orcid.org/0000-0002-1679-957X
Jannik EschenbachInstitute of Biochemistry, University of Münster Corrensstr. 36 D-48149 Münster Germany mittonfryr@denison.edu andrea.rentmeister@cup.lmu.de cornelissen@uni-muenster.de.ORCID https://orcid.org/0009-0004-0902-9819
Helena SchepersInstitute of Biochemistry, University of Münster Corrensstr. 36 D-48149 Münster Germany mittonfryr@denison.edu andrea.rentmeister@cup.lmu.de cornelissen@uni-muenster.de.
René RascheInstitute of Biochemistry, University of Münster Corrensstr. 36 D-48149 Münster Germany mittonfryr@denison.edu andrea.rentmeister@cup.lmu.de cornelissen@uni-muenster.de.ORCID https://orcid.org/0000-0002-5821-3557
Mehmet ErguvenInstitute of Biochemistry, University of Münster Corrensstr. 36 D-48149 Münster Germany mittonfryr@denison.edu andrea.rentmeister@cup.lmu.de cornelissen@uni-muenster.de.ORCID https://orcid.org/0000-0001-5947-8568
Daniel KümmelInstitute of Biochemistry, University of Münster Corrensstr. 36 D-48149 Münster Germany mittonfryr@denison.edu andrea.rentmeister@cup.lmu.de cornelissen@uni-muenster.de.ORCID https://orcid.org/0000-0003-3950-5914
Andrea RentmeisterInstitute of Biochemistry, University of Münster Corrensstr. 36 D-48149 Münster Germany mittonfryr@denison.edu andrea.rentmeister@cup.lmu.de cornelissen@uni-muenster.de.ORCID https://orcid.org/0000-0002-3107-4147
Nicolas V CornelissenInstitute of Biochemistry, University of Münster Corrensstr. 36 D-48149 Münster Germany mittonfryr@denison.edu andrea.rentmeister@cup.lmu.de cornelissen@uni-muenster.de.ORCID https://orcid.org/0000-0002-3625-7612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Base-modified adenosine-5'-triphosphate (ATP) analogues are highly sought after as building blocks for mRNAs and non-coding RNAs, for genetic code expansion or as inhibitors. Current synthetic strategies lack efficient and robust 5'-triphosphorylation of adenosine derivatives or rely on costly phosphorylation reagents. Here, we combine the efficient organic synthesis of base-modified AMP analogues with enzymatic phosphorylation by a promiscuous polyphosphate kinase 2 class III from an unclassified

Identifiers

PMID39148801
PMCPMC11322958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.